Quarterly report pursuant to Section 13 or 15(d)

WARRANTS

v3.20.2
WARRANTS
 6 Months Ended
Sep. 30, 2020
WARRANTS  
WARRANTS

12.     WARRANTS

The following is a continuity schedule of the Company’s common share purchase warrants:

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Number of

 

Exercise Price 

 

    

 Warrants

    

($)

Outstanding and exercisable, March 31, 2019

 

288,517

 

40.27

Expired

 

(163,483)

 

(38.91)

Outstanding and exercisable, March 31, 2020

 

125,034

 

20.07

Expired

 

(2,667)

 

(37.50)

Outstanding and exercisable September 30, 2020

 

122,367

 

19.69

 

During the  six months ended September 30, 2020, 2,667 warrants expired in accordance with their terms.

Common share purchase warrants

The following is a summary of common share purchase warrants outstanding as of September 30, 2020.

 

 

 

 

 

 

Exercise 

    

Number of 

    

 

Price ($)

 

Warrants

 

Expiry Date

90.00

 

15,658

 

March 31, 2023

9.375

 

64,025

 

August 14, 2022

9.375

 

42,684

 

March 31, 2022

 

 

122,367

 

 

 

The weighted-average remaining contractual term of the outstanding warrants was 1.82.